Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US-12006555-B2 · Jun 11, 2024 · US
Settleman Jeffrey E is listed as an inventor on 14 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Settleman Jeffrey E |
| Total patents | 14 |
| First publication | Apr 30, 2015 |
| Latest publication | Jun 11, 2024 |
Publications ranked by popularity score, then publication date.
US-12006555-B2 · Jun 11, 2024 · US
US-2023226039-A1 · Jul 20, 2023 · US
US-10953013-B2 · Mar 23, 2021 · US
US-2021017604-A1 · Jan 21, 2021 · US
US-10669589-B2 · Jun 2, 2020 · US
US-10603314-B2 · Mar 31, 2020 · US
US-10596162-B2 · Mar 24, 2020 · US
US-2018251860-A1 · Sep 6, 2018 · US
US-10000815-B2 · Jun 19, 2018 · US
US-2017105995-A1 · Apr 20, 2017 · US
Latest publications not already listed above.
US-2016310482-A1 · Oct 27, 2016 · US
US-2015176081-A1 · Jun 25, 2015 · US
US-9035036-B2 · May 19, 2015 · US
US-2015119410-A1 · Apr 30, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Massachusetts Gen Hospital | 12 |
| Dana Farber Cancer Inst Inc | 8 |
| Wyeth Llc | 4 |
| Millennium Pharm Inc | 4 |
| Gen Hospital Corp | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 14 |
| A61P35/00 | 14 |
| G01N2800/52 | 10 |
| C12Q2600/156 | 10 |
| C12Q2600/106 | 10 |